Insight Study For Repurposing Of Certain Anti‐Inflammatory Drugs Based On Aspirin and Salicylic Acid Scaffolds For The Treatment of Cancer as CDKs Inhibitors: Cheminformatics and Anticancer Studies
ChemistrySelect,
Journal Year:
2025,
Volume and Issue:
10(15)
Published: April 1, 2025
Abstract
The
highly
increased
and
global
mortality
due
to
cancer
has
created
an
urgent
need
discover
promising
targets
for
its
treatment.
Where
drug
repurposing
was
considered
as
attractive
approach
that
can
facilitate
the
lead
generation
optimization
phases
of
discovery
by
existing
agents
target
diseases
other
than
their
primary
uses.
Cheminformatics
studies
represented
in
molecular
docking
well
dynamic
simulation
salicylic
acid
/
aspirin
analogues
sulindac
indomethacin
anti‐inflammatory
drugs
were
carried
out
be
used
cyclin‐dependent
kinases
(CDKs)
namely
CDK2,
CDK6,
CDK12
inhibitors.
Sulindac
displayed
best
binding
ligand
all
receptors.
CDKs
inhibition
effects
three
sulindac,
anthranilic
demonstrated
good
inhibitory
activity
against
ranging
from
0.48
1.78
µM.
Likewise,
cytotoxicity
revealed
potent
anticancer
0.155
1.278
µM
cell
lines:
HCT‐116,
MCF‐7,
HeLa
cells.
As
a
result,
this
technique
saves
lot
time
money
order
new
agents.
Language: Английский
Preparation and Characterization of Tadalafil-loaded Hydrogel: An in-vivo Evaluation of Wound Healing Activity
Anita Sadat Haji Seyed Javadi Pajouhi,
No information about this author
Amir Larki-Harcheghani,
No information about this author
Mojdeh Mohammadi
No information about this author
et al.
Pharmaceutical Science Advances,
Journal Year:
2025,
Volume and Issue:
unknown, P. 100066 - 100066
Published: Feb. 1, 2025
Language: Английский
Inhibitors of Cyclic Dinucleotide Phosphodiesterases and Cyclic Oligonucleotide Ring Nucleases as Potential Drugs for Various Diseases
Cells,
Journal Year:
2025,
Volume and Issue:
14(9), P. 663 - 663
Published: April 30, 2025
The
phosphodiester
linkage
is
found
in
DNA,
RNA
and
many
signaling
molecules,
such
as
cyclic
mononucleotide,
dinucleotides
(CDNs)
oligonucleotides
(cONs).
Enzymes
that
cleave
the
(nucleases
phosphodiesterases)
play
important
roles
cell
persistence
fitness
have
therefore
become
targets
for
various
diseased
states.
While
inhibitors
been
developed
nucleases
mononucleotide
phosphodiesterases,
some
clinical
successes,
there
a
paucity
of
recently
discovered
phosphodiesterases
or
ring
CDNs
cONs.
Inhibitors
bacterial
c-di-GMP
c-di-AMP
potential
to
be
used
anti-virulence
compounds,
while
compounds
inhibit
degradation
3′,3′-cGAMP,
cA3,
cA4,
cA6
could
serve
antibiotic
adjuvants
accumulation
these
second
messengers
leads
abortive
infection.
In
humans,
2′3′-cGAMP
plays
critical
antiviral
antitumor
responses.
ENPP1
(the
phosphodiesterase)
virally
encoded
dinucleotide
poxin,
however,
blunt
this
response.
poxin-like
enzymes
anticancer
agents,
respectively.
This
review
summarizes
efforts
made
towards
discovery
development
CDN
cON
nucleases.
Language: Английский